## **Core Concept**
The question describes a clinical scenario suggestive of a glycogen storage disease (GSD), characterized by hepatomegaly, hypoglycemia, hyperlipidemia, acidosis, and normal structured glycogen deposition in the liver. Glycogen storage diseases are a group of genetic disorders caused by deficiencies in enzymes involved in glycogen synthesis or breakdown.

## **Why the Correct Answer is Right**
The correct answer, **D.**, corresponds to Glycogen Storage Disease Type I (GSD I), also known as von Gierke's disease. This condition is caused by a deficiency of glucose-6-phosphatase, an enzyme crucial for the final steps of glucose production from glycogen and gluconeogenesis. The deficiency leads to an inability to convert glucose-6-phosphate into glucose for release into the bloodstream, resulting in severe hypoglycemia, hepatomegaly due to glycogen accumulation, hyperlipidemia, and lactic acidosis. The glycogen in GSD I is structurally normal but accumulated due to the enzymatic block.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option would be incorrect because it does not specify a known glycogen storage disease related to the symptoms provided.
- **Option B:** This could potentially refer to another glycogen storage disease but does not match the specific clinical presentation given.
- **Option C:** This option is also incorrect as it does not align with the clinical and biochemical features described.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for GSD I (von Gierke's disease) is the presence of "liver enlargement" and "severe hypoglycemia" which are hallmark features. Additionally, patients with GSD I are at risk for complications such as gout, kidney stones, and hepatic adenomas. A classic laboratory finding is lactic acidosis, which helps differentiate it from other causes of hypoglycemia and hepatomegaly.

## **Correct Answer: D. von Gierke's disease**